As of 2026-03-15, the Intrinsic Value of Ose Immunotherapeutics SA (OSE.PA) is 22.53 EUR. This OSE.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 3.68 EUR, the upside of Ose Immunotherapeutics SA is 512.30%.
The range of the Intrinsic Value is 18.93 - 27.81 EUR
Based on its market price of 3.68 EUR and our intrinsic valuation, Ose Immunotherapeutics SA (OSE.PA) is undervalued by 512.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 18.93 - 27.81 | 22.53 | 512.3% |
| DCF (Growth 10y) | 22.04 - 31.72 | 25.99 | 606.4% |
| DCF (EBITDA 5y) | 21.11 - 28.96 | 24.84 | 575.1% |
| DCF (EBITDA 10y) | 23.15 - 31.90 | 27.15 | 637.9% |
| Fair Value | -7.75 - -7.75 | -7.75 | -310.73% |
| P/E | (10.45) - 10.32 | (3.14) | -185.4% |
| EV/EBITDA | 10.15 - 25.14 | 16.70 | 353.9% |
| EPV | (0.70) - (0.73) | (0.71) | -119.4% |
| DDM - Stable | (7.07) - (13.73) | (10.40) | -382.5% |
| DDM - Multi | 10.00 - 16.08 | 12.41 | 237.1% |
| Market Cap (mil) | 82.65 |
| Beta | 1.23 |
| Outstanding shares (mil) | 22.46 |
| Enterprise Value (mil) | 95.92 |
| Market risk premium | 5.82% |
| Cost of Equity | 13.27% |
| Cost of Debt | 5.00% |
| WACC | 10.42% |